Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing
Members do not see these Ads. Sign Up.
M. Muller, C. Trocme, B. Lardy, F. Morel, S. Halimi, P. Y. Benhamou
Diabetic Medicine 25 (4) , 419–426 2008
<
Resina Draconis for wound repair in the treatment of diabetic foot ulcer
|
Ischemic Charcot foot
>
-
-
Related threads:
Diabetic foot surgery: classifying patients to predict complications
Predicting diabetic foot ulcer outcomes - differences with PVD
Predictors of treatment failure for diabetic foot infections
Initial percent change in wound size can predict outcome
Neurovascular status did not affect wound closure rate
Scottish Foot Ulcer Risk Score Predicts Foot Ulcer Healing -
Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers
Yu Liu, Danqing Min, Thyra Bolton, Vanessa Nubé, Stephen M. Twigg, Dennis K. Yue and Susan V. McLennan
Diabetes Care Publish Ahead of Print published online ahead of print October 3, 2008
-
Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers
Zhihong Lia, Shuqin Guoa, Fang Yaob,Yunliang Zhangb, Tingting Lia
Journal of Diabetes and its Complications; Available online 26 January 2013
-
Effect of Daptomycin on Local Interleukin-6, Matrix Metalloproteinase-9, and Metallopeptidase Inhibitor 1 in Patients With MRSA-Infected Diabetic Foot
Andreas Ambrosch et al
International Journal of Lower Extremity Wounds June 2013 vol. 12 no. 2 100-105
-
Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes.
Kim HS, Yoo HS.
Gene Ther. 2013 Apr;20(4):378-85.
-
A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers
Kanhaiya Singh, Neeraj K. Agrawal, Sanjeev K. Gupta, Kiran Singh
International Journal of Lower Extremity Wounds September 16,
-
Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity
Kanhaiya Singh et al
International Journal of Lower Extremity Wounds June 2014 vol. 13 no. 2 94-102
-
Neutrophil Associated Lipocalin-2 (NGAL) Is Increased and Associates with Increased MMP-9 Activity in an Implant Model of Diabetic Wound Healing
MARYAM ABDOLLAHI, SARAH AAMIDOR, TARIA NG, ALIREZA REZAEIZADEH, DANQING MIN, STEPHEN M. TWIGG, SUSAN MCLENNAN
Presented at the 74th American Diabetes Association Mtg; San Francisco; June 14-17 2014
-
High Matrix Metalloproteinase Levels Are Associated With Dermal Graft Failure in Diabetic Foot Ulcers
Valentina Izzo et al
International Journal of Lower Extremity Wounds August 8, 2014
-
-
STUDY ON MATRIX METALLOPROTEINASES IN DIABETIC FOOT ULCER DISEASE
Julie Susan Sam
Vol 4, No 3 (2015)
-
Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence.
Lazaro JL et al
J Wound Care. 2016 May;25(5):277-87
-
The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.
Ayuk SM et al
J Diabetes Res. 2016;2016:2897656.
-
The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series
Izzo Valentina, Meloni Marco, Giurato Laura, Ruotolo Valeria, and Uccioli Luigi. Advances in Wound Care. October 2016, ahead of print. doi:10.1089/wound.2016.0700.
Advances in Wound Care October 20, 2016
-
The effect of a common antibiotics doxycycline on non-healing chronic wound.
Xu DH et al
Curr Pharm Biotechnol. 2017 May 18. doi: 10.2174/1389201018666170519095339
-
Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers.
Li G etal
Int J Low Extrem Wounds. 2017 Mar;16(1):6-13. doi: 10.1177/1534734617696728.
-
Biological Activity and Implications of the Metalloproteinases in Diabetic Foot Ulcers
Claudia Castruita-De la Rosa et al
Biochemistry, Genetics and Molecular Biology
-
Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
Nguyen TT et al
European Journal of Pharmacology [13 Jul 2018]
-
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor that Accelerates Healing.
Nguyen TT, Ding D, Wolter WR, Perez RL, Champion MM, Mahasenan KV, Hesek D, Lee M, Schroeder VA, Jones JI, Lastochkin E, Rose MK, Peterson CE, Suckow MA, Mobashery S, Chang M.
J Med Chem. 2018 Sep 13
-
Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers
Punyanuch Jindatanmanusan et al
Pathology Research International; Volume 2018, Article ID 1631325, 5 pages
-
Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound
Ying LiangChuan YangYongqing LinYasir ParvizKan SunWei WangMeng RenEmail authorLi Yan
Apoptosis: 04 April 2019
-
Targeting MMP-9 in Diabetic Foot Ulcers
Jeffrey I. Jones, Trung T. Nguyen, Zhihong Peng and Mayland Chang
Pharmaceuticals 2019, 12, 79;
-
Swift Downregulation of Gelatinases (MMP-2, MMP-9) in Neuropathic Diabetic Foot Ulcers Treated With Total Contact Cast.
Alvarez OM et al
Wounds : a Compendium of Clinical Research and Practice [01 May 2019, 31(5):E39-E41]
-
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
Fields GB
Cells. 2019 Aug 27 ;8(9)
-
Local release of metalloproteinases and their inhibitors after a successful revascularisation procedure
Raffaele Grande Gioia Brachini Antonio V. Sterpetti Valeria Borrelli Raffaele Serra Francesco Pugliese Giuseppe D'Ermo Elvira Tartaglia Paolo Rubino Andrea Mingoli Paolo Sapienza
27 October 2019
-
Efficacy of MMP-inhibiting wound dressings in the treatment of hard-to-heal wounds: a systematic review.
Dissemond J et al
J Wound Care. 2020 Feb 2;29(2)
-
Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound.
Liang Y et al
Apoptosis. 2019 Aug;24(7-8):542-551
-
High Glucose Activates ERK1/2 to Stabilize AP1 and Increase MMP9 Expression in Diabetic Foot Ulcers
Jiangli Lang et al
Exp Cell Res. 2021 Mar 3
-
Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial
Rokhsareh Meamar et al
Pharmacol Rep. 2021 Apr 7
-
A Review: Matrix Metallopeptidase-9 Nanoparticles Targeted for the Treatment of Diabetic Foot Ulcers
Wakuma Wakene Jifar et al
J Multidiscip Healthc. 2021 Dec 1;14:3321-3329
-
Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
Kang Fu et al
Front Pharmacol. 2022 Oct 20
-
Efficiency and Safety of Dextran-PAMAM/siMMP-9 Complexes for Decreasing Matrix Metalloproteinase-9 Expression and Promoting Wound Healing in Diabetic Rats
Heng-Cong Luo et al
Bioconjugate Chem. 2022,
<
Resina Draconis for wound repair in the treatment of diabetic foot ulcer
|
Ischemic Charcot foot
>
Loading...
- Similar Threads - Ratio metalloproteinases predict
-
- Replies:
- 0
- Views:
- 202
-
- Replies:
- 1
- Views:
- 991
-
- Replies:
- 1
- Views:
- 586
-
- Replies:
- 2
- Views:
- 743
-
- Replies:
- 1
- Views:
- 1,205
-
- Replies:
- 1
- Views:
- 502
-
- Replies:
- 8
- Views:
- 1,014